|
1
|
Keller S, Inai R, Sato S, Tada A, Adam G,
Yamamura J and Kanazawa S: Thallium-201 uptake of giant cell tumor:
One step toward the differential diagnosis to atypically presenting
osteosarcoma. AJR Am J Roentgenol. 208:171–179. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhou C, Shen Q, Xue J, Ji C and Chen J:
Overexpression of TTRAP inhibits cell growth and induces apoptosis
in osteosarcoma cells. BMB Rep. 46:113–118. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lu KH, Yang HW, Su CW, Lue KH, Yang SF and
Hsieh YS: Phyllanthus urinaria suppresses human osteosarcoma cell
invasion and migration by transcriptionally inhibiting u-PA via ERK
and Akt signaling pathways. Food Chem Toxicol. 52:193–199. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Enomoto A, Ping J and Takahashi M: Girdin,
a novel actin-binding protein, and its family of proteins possess
versatile functions in the Akt and Wnt signaling pathways. Ann N Y
Acad Sci. 1086:169–184. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Miyake H, Maeda K, Asai N, Shibata R,
Ichimiya H, Isotani-Sakakibara M, Yamamura Y, Kato K, Enomoto A,
Takahashi M and Murohara T: The actin-binding protein Girdin and
its Akt-mediated phosphorylation regulate neointima formation after
vascular injury. Circ Res. 108:1170–1179. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Adams SJ, Aydin IT and Celebi JT: GAB2-a
scaffolding protein in cancer. Mol Cancer Res. 10:1265–1270. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xu XL, Wang X, Chen ZL, Jin M, Yang W,
Zhao GF and Li JW: Overexpression of Grb2-associated binder 2 in
human lung cancer. Int J Biol Sci. 7:496–504. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang B, Gu F, She C, Guo H, Li W, Niu R,
Fu L, Zhang N and Ma Y: Reduction of Akt2 inhibits migration and
invasion of glioma cells. Int J Cancer. 125:585–595. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee SH, Kang YY, Jang HE and Mok H:
Current preclinical small interfering RNA (siRNA)-based conjugate
systems for RNA therapeutics. Adv Drug Deliv Rev. 104:78–92. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ruigrok MJR, Frijlink HW and Hinrichs WLJ:
Pulmonary administration of small interfering RNA: The route to go?
J Control Release. 235:14–23. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Enomoto A, Murakami H, Asai N, Morone N,
Watanabe T, Kawai K, Murakumo Y, Usukura J, Kaibuchi K and
Takahashi M: Akt/PKB regulates actin organization and cell motility
via Girdin/APE. Dev Cell. 9:389–402. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Simister PC and Feller SM: Order and
disorder in large multi-site docking proteins of the Gab
family-implications for signalling complex formation and inhibitor
design strategies. Mol Biosyst. 8:33–46. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hunzicker-Dunn ME, Lopez-Biladeau B, Law
NC, Fiedler SE, Carr DW and Maizels ET: PKA and GAB2 play central
roles in the FSH signaling pathway to PI3K and AKT in ovarian
granulosa cells. Proc Natl Acad Sci USA. 109:pp. E2979–E2988. 2012;
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nasrazadani A and Van Den Berg CL: c-Jun
N-terminal kinase 2 regulates multiple receptor tyrosine kinase
pathways in mouse mammary tumor growth and metastasis. Genes
Cancer. 2:31–45. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nyga R, Pecquet C, Harir N, Gu H,
Dhennin-Duthille I, Régnier A, Gouilleux-Gruart V, Lassoued K and
Gouilleux F: Activated STAT5 proteins induce activation of the PI
3-kinase/Akt and Ras/MAPK pathways via the Gab2 scaffolding
adapter. Biochem J. 390:359–366. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bocanegra M, Bergamaschi A, Kim YH, Miller
MA, Rajput AB, Kao J, Langerød A, Han W, Noh DY, Jeffrey SS, et al:
Focal amplification and oncogene dependency of GAB2 in breast
cancer. Oncogene. 29:774–779. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fleuren ED, O'Toole S, Millar EK, McNeil
C, Lopez-Knowles E, Boulghourjian A, Croucher DR, Schramek D,
Brummer T, Penninger JM, et al: Overexpression of the oncogenic
signal transducer Gab2 occurs early in breast cancer development.
Int J Cancer. 127:1486–1492. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Y, Sheng Q, Spillman MA, Behbakht K
and Gu H: Gab2 regulates the migratory behaviors and E-cadherin
expression via activation of the PI3K pathway in ovarian cancer
cells. Oncogene. 31:2512–2520. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang X, Lavoie G, Fort L, Huttlin EL,
Tcherkezian J, Galan JA, Gu H, Gygi SP, Carreno S and Roux PP: Gab2
phosphorylation by RSK inhibits Shp2 recruitment and cell motility.
Mol Cell Biol. 33:1657–1670. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Brown LA, Kalloger SE, Miller MA, Shih
IeM, McKinney SE, Santos JL, Swenerton K, Spellman PT, Gray J,
Gilks CB and Huntsman DG: Amplification of 11q13 in ovarian
carcinoma. Genes Chromosomes Cancer. 47:481–489. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Schraml P, Schwerdtfeger G, Burkhalter F,
Raggi A, Schmidt D, Ruffalo T, King W, Wilber K, Mihatsch MJ and
Moch H: Combined array comparative genomic hybridization and tissue
microarray analysis suggest PAK1 at 11q13.5-q14 as a critical
oncogene target in ovarian carcinoma. Am J Pathol. 163:985–992.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Izquierdo M: Short interfering RNAs as a
tool for cancer gene therapy. Cancer Gene Ther. 12:217–227. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sinn PL, Sauter SL and McCray PB Jr: Gene
therapy progress and prospects: Development of improved lentiviral
and retroviral vectors-design, biosafety, and production. Gene
Ther. 12:1089–1098. 2005. View Article : Google Scholar : PubMed/NCBI
|
